today announced that it will present a poster highlighting preclinical evaluation of IM-1021, a ROR1-targeted antibody drug conjugate (ADC), at the 36 th EORTC-NCI-AACR Symposium on Molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback